After the publication of a major study in the New England Journal of Medicine, the world's most prestigious medical journal, in 2006, intraperitoneal chemotherapy was recognized as the new standard for the treatment of ovarian cancer. It is performed by injecting drugs not only into a vein, but also directly into the abdominal cavity, where residual cancer cells are located. It has been proven that survival after intraperitoneal chemotherapy increases by almost one and a half years compared with traditional chemotherapy, and the chances of a complete cure also increase.
Intraperitoneal chemotherapy requires the complete removal of all visible tumor foci during surgery, as well as the installation of a special device under the skin to inject chemotherapy drugs into the abdominal cavity. This is usually done at the end of the main surgery, but it can also be performed before the start of postoperative chemotherapy.
This type of chemotherapy is the standard of treatment in the USA, Canada and Western European countries, but unfortunately it has not yet found wide application in Russia.
Our patients have a unique opportunity to undergo a full preoperative diagnosis for suspected ovarian cancer, the most complete surgery performed by an experienced certified American oncogynecologist, as well as postoperative chemotherapy (including intraperitoneal) by an American certified oncologist-chemotherapist.
.webp)
.webp)
.webp)
